Prime Therapeutics hires industry veteran Mike Edwards to lead new market-focused organization 

Edwards joins as president, markets

June 10, 2024

Mike Edwards

Today, Prime Therapeutics, LLC/Magellan Rx Management (Prime/MRx) announces the appointment of health care leader Mike Edwards as president, markets. Edwards will oversee Prime/MRx’s growth and client engagement teams across all market segments. 

Mostafa Kamal“Mike is an accomplished leader with deep expertise in our business and a proven track record. I am thrilled he is joining our leadership team as we sharpen our focus on delivering differentiated solutions and service to our clients. Under Mike’s leadership, we will bring together our enterprise-wide sales, client engagement, and Medicare and Medicaid teams with a laser focus on being consultative partners with our clients to deeply understand their strategies and needs.”Mostafa Kamal, president and chief executive officer

Over the course of his career, Edwards has been instrumental in building and leading high-performing teams across our industry. Most recently, Edwards served as chief executive officer at MedMinder and chief commercial officer at Truveris. Previously, Edwards held various executive roles at Optum, including president, commercial markets at OptumRx, UnitedHealth Group’s pharmacy business. Edwards also served as chief growth officer where he led go-to market functions, including sales and account management across all market segments. Additionally, Edwards held various senior leadership roles at Catamaran, Express Scripts and Medco. 

“In today’s rapidly evolving market, Prime is positioned to help clients solve their most complex challenges and deliver better experiences for their members and employees,” Edwards said. “I’m extremely excited about the opportunity to work with the Prime team and all of its clients.” 

Edwards received his bachelor’s degree from Rutgers University and a master’s degree from New Jersey Institute of Technology (NJIT) in International Business Finance and a Master of Business Administration in the Management of Technology.  

Related news

Press releases

April 11, 2024

Prime Therapeutics and Magellan Rx to present eight managed care pharmacy research studies at AMCP

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting

Press releases

March 13, 2024

Prime Therapeutics and Capital Rx Enter Into Transformative Strategic Alliance

Strategic alliance allows Prime to offer exclusive access to Capital Rx’s leading technology platform to achieve a higher standard of care, increase efficiency, improve experiences and provide the foundation for the next generation of integrated pharmacy care for the more than 50 million Americans served by Prime

Press releases

February 8, 2024

Magellan Rx Management, LLC earns URAC Accreditation in Health Utilization Management

Designation demonstrates highest level of commitment to quality health care